Secondaries announced 12.08.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Recro Pharma, Inc. Symbol: REPH Price: Last trade $6.99 Trade Date: 12/13 Shares: 5.7 million Underwriter(s)Piper Jaffray Rating=Subscription Needed Company: Valley[…]